Molecular requirements for epithelial-mesenchymal transition during tumor progression
- PMID: 16098727
- DOI: 10.1016/j.ceb.2005.08.001
Molecular requirements for epithelial-mesenchymal transition during tumor progression
Abstract
Epithelial-mesenchymal transitions (EMTs) occur as key steps during embryonic morphogenesis, and are now implicated in the progression of primary tumors towards metastases. Recent advances have fostered a more detailed understanding of molecular mechanisms and networks governing EMT in tumor progression. Besides TGFbeta and RTK/Ras signaling, autocrine factors and Wnt-, Notch-, Hedgehog- and NF-kappaB-dependent pathways were found to contribute to EMT. Repression of E-cadherin by transcriptional regulators such as Snail or Twist emerges as one critical step driving EMT, and this stage is currently being molecularly linked with many of the new players. Increasing evidence suggests that EMT plays a specific role in the migration of cells from a primary tumor into the circulation and may provide a rationale for developing more effective cancer therapies.
Similar articles
-
Epithelial-mesenchymal transition in gastric cancer (Review).Int J Oncol. 2005 Dec;27(6):1677-83. Int J Oncol. 2005. PMID: 16273224 Review.
-
Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.Cells Tissues Organs. 2007;185(1-3):85-94. doi: 10.1159/000101307. Cells Tissues Organs. 2007. PMID: 17587812 Review.
-
Epithelial-mesenchymal transitions: twist in development and metastasis.Cell. 2004 Aug 6;118(3):277-9. doi: 10.1016/j.cell.2004.07.011. Cell. 2004. PMID: 15294153 Review.
-
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.Drug Resist Updat. 2008 Aug-Oct;11(4-5):123-51. doi: 10.1016/j.drup.2008.07.001. Epub 2008 Aug 20. Drug Resist Updat. 2008. PMID: 18718806 Review.
-
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4147-53. doi: 10.1158/1078-0432.CCR-06-0038. Clin Cancer Res. 2006. PMID: 16857785
Cited by
-
Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors.PLoS One. 2013;8(3):e58719. doi: 10.1371/journal.pone.0058719. Epub 2013 Mar 14. PLoS One. 2013. PMID: 23516540 Free PMC article.
-
Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.Prostate. 2020 Sep;80(12):926-937. doi: 10.1002/pros.24015. Epub 2020 Jun 16. Prostate. 2020. PMID: 32542812 Free PMC article.
-
Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p.J Neurooncol. 2022 Oct;160(1):67-78. doi: 10.1007/s11060-022-04113-5. Epub 2022 Sep 12. J Neurooncol. 2022. PMID: 36094613
-
Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.Breast Cancer Res. 2012 Dec 6;14(6):R154. doi: 10.1186/bcr3367. Breast Cancer Res. 2012. PMID: 23216791 Free PMC article.
-
Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.BMC Cancer. 2013 Apr 1;13:171. doi: 10.1186/1471-2407-13-171. BMC Cancer. 2013. PMID: 23548172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials